Fund profile / France

Andera Partners BioDiscovery Fund VII

Geography: France
Stage: Growth
Fund size: €300M
Focus: Biotech, MedTech and Therapeutics
Signals: Published

N°01 / About

About Andera Partners BioDiscovery Fund VII

First close at €300M+, target >€500M

N°02 / Thesis

Investment Focus

Location / RegionFrance

Funding StageGrowth

Industry Focus

Biotech

MedTech

Therapeutics

Investor Signals Profile

active

Sweet Spot

Growth-stage European company in life sciences or midcap

life sciences

mid-cap buyout

expansion capital

infrastructure

sponsorless mezzanine

Bullish Signals

€6B AUM, 377 portfolio companies 20+ yearswebsite

131 professionals, 15 internal promotions 2026website

Acto V closed €1.1B, above hard capexternal

Andera Expansion IV €430M record fundraisewebsite

Tubulis acquired by Gilead, up to $5Bwebsite

Agomab Nasdaq listing, $200M raisedexternal

Real Deals Best Multi-Strategy House 2026website

Joins European Life Sciences Coalition ELSCwebsite

Rivermark Medical $20M Series D ledwebsite

Inventiva Pharma $120M equity + €150M debtexternal

Acto celebrates 20 years sponsorless mezzanineexternal

2025 ESG Report published, sustainability-focusedwebsite

Women In Finance France partnership announcedexternal

Real Deals Sustainable Investment Awards shortlistedexternal

PE Magazine Top 3 ranking SMID fundexternal

6 strategies: Life Sciences, MidCap, Expansion, Acto, Infra, Co-Investwebsite

Spain expansion accelerating via Joaquín Gonzalowebsite

JenaValve FDA approval, first-of-kind deviceexternal

Alveus $160M Series A co-ledexternal

Spiro Medical $67M Series A ledexternal

Frankfurt office opened, Germany footprint deepenedwebsite

Nostrum Group NASDAQ exit via Andera Infrawebsite

Tecnikabel USA expansion via MidCap strategywebsite

exceet Card Group Austrian investment via Actowebsite

Power of And: partnership conviction core missionwebsite

S4BT acquires HotelHub, global business travelwebsite

Sustainability White Paper: business value driverwebsite

Health is Wealth: Europe life sciences mobilizationwebsite

Contrarian Signals

Large platform, less agile for small cosexternal

6 siloed strategies — complex fit assessmentexternal

French-language comms — Paris-centric cultureexternal

Founder Do's

Show strong sustainable growth trajectory

Seek long-term partnership mindset

Highlight international expansion potential

Fit into defined strategy: biotech, midcap, infra

Emphasise ESG credentials — active ESG programme

Founder Don'ts

Expect early-stage seed funding

Pitch outside defined sector strategies

Underestimate partnership culture fit

42 signals on Andera Partners BioDiscovery Fund VII

28 bullish · 3 contrarian · 5 pitch do's · 3 don'ts · 3 GP profiles, each with its source. From €9/month, cancel anytime.

See a signal free View Plans Browse all Signal Profiles →

Facts

Fund Overview

Fund Size€300M

Saves0

Website

People

Key People

Sofia Ioannidou, Gilles Nobécourt, Olivier Litzka, Raphaël Wisniewski, Jan Van den Bossche

Bruno AnglesStrategic Advisor

Joaquín GonzaloSenior Advisor (Spain)

Vincent BazzocchiPartner (MidCap)

Backers

Known LPs

KfW CapitalPublic / State institution

N°04 / See also

Related Funds

4elements

Fund size€27M

Location: France
Stage: Pre Seed
Focus: Climate Sustainability, Ai Ml, Saas
Manager: Cédric Favier, Jean Baptiste Goffart

Pre Seed

Climate Sustainability

Ai Ml

Saas

Axeleo Capital (AXC)

Fund size€125M

Location: France
Stage: Pre Seed
Focus: Saas
Manager: Eric Burdier

Pre Seed

Saas

Mérieux Innovation 2 (MI2)

Fund size€150M

Location: France
Stage: Pre Seed
Focus: Digital Health
Manager: Valérie Calenda, Yoann Bonnamour

Pre Seed

Digital Health